SOD1 and Alzheimer disease: Conclusively, administration of WIN55,212-2 ameliorated cognitive impairments in AlCl3− and d-gal-induced rats’ model of AD as the administration of WIN55,212-2 reversed oxidative stress by reducing the levels of MDA and increasing the levels of SOD and GSH in the rats’ brains.